Impact of Vitamin C on Biomarkers of Neurologic Injury in Survivors of Cardiac Arrest

A phase 2 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 150 participants.

Also called NCT04563000

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; triple masking; primary purpose treatment
Phase
Phase 2
Enrolled
  • 150 participants (planned count) (from the registry)
Sponsor
University Medical Centre Maribor (from the registry)
Registry
  • NCT NCT04563000
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Slovenia (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT04563000. Randomized; triple masking; primary purpose treatment. Start 2020-10-01 (anticipated); primary completion 2022-10-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Impact of Vitamin C on Biomarkers of Neurologic Injury in Survivors of Cardiac Arrest
Condition
Heart Arrest, Out-Of-Hospital
Condition
Biomarkers
Condition
Oxidative Stress
Condition
Neurological Injury
Intervention (Drug)
Vitamin C
Intervention (Drug)
Placebo
Lead sponsor
University Medical Centre Maribor (class: other)

Record details

Record id
cardio:ct-nct04563000
Content hash
da146a3b717481f4efaa0469f06e1c2a06a567cede33da9be95f7eb0ea384ffc